Jasbir Seehra serves as Executive at Keros Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Jasbir Seehra has executed 5 insider transactions totaling $320.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 3, 2025 involved receiving (via award) 90,500 shares valued at $0.
Jasbir Seehra currently holds 392,723 shares of Keros Therapeutics, Inc. (KROS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jasbir Seehra has been a net buyer of KROS stock. They have purchased $320.0K and sold $0 worth of shares.
Jasbir Seehra's most recent insider trade was on Sep 3, 2025, when they sold 90,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.48 |
| Discretionary |
| Jun 9, 2022 | KROS | $1.5K | Option Exercise | 5,000 | $0.30 | Discretionary |
| Apr 13, 2020 | KROS | $320.0K | Purchase | 20,000 | $16.00 | Discretionary |
| Apr 13, 2020 | KROS | $0 | Conversion | 11,169 | $N/A | Discretionary |